Scientists have discovered the mechanism which allows the superbug Methicillin Resistant Staphylococcus aureus (MRSA) to become highly resistant to antibiotics, paving the way for new approaches to control infectious disease.
The $2.7B Precision/Eli Lilly deal gets modified; Abeona closes $25M direct offering
A deal between Precision BioSciences and Eli Lilly has now been modified with lower milestones. Precision announced the change in an SEC filing, saying the